 ImmunoSite Technologies Expands into New Spacious Facility in Miramar |
| Published Thursday, February 28, 2013 |
ImmunoSite Technologies, LLC (IST), a provider of automation, design and customization of complex biological assays to biotechnology and pharmaceutical industries worldwide, announced its relocation to a newly expanded facility at 2831 Corporate Way in Miramar. With the expansion, the company will be retaining its current 6 employees, making a capital investment of $150,000 and adding 5 new jobs that will focus on product development.
CEO and President of ImmunoSite Technologies, LLC, Carlos Aparicio, Ph.D., who has almost 20 years experience in technical and scientific leadership in the pharmaceutical and medical devices industries, said, “ImmunoSite is perfectly positioned to support our clients’ increasing needs for worldwide automation and standardization of biological assays. As a result, we committed to expand our headquarters to a new location in the Miramar Park of Commerce, Miramar, FL, in December 2012, where we could accommodate the increased scientific and administrative staff and the large robotic systems.”
City of Miramar Mayor Lori Moseley stated, “The city is pleased to welcome ImmunoSite Technologies to our community and is excited that their biotechnology expertise further diversifies our corporate base. It is our pleasure to have provided an expedited permitting process for the company which allowed it to become operational within a month’s time.”
“The expansion of ImmunoSite Technologies and other life science firms are the real success stories of Broward County,” said Mason Jackson, president and CEO of WorkForce One Employment Solutions. “WorkForce One looks forward to growing this business sector by continuing to work with ImmunoSite through the recruitment and training process of their employees.”
“Floridian Community Bank partnered with ImmunoSite Technologies on their move to Miramar and expansion efforts by providing working capital financing to the company. We are impressed with the quality of management and excited about future opportunities to continue funding the growth of ImmunoSite,” commented Scott Toth, commercial market manager for Floridian Community Bank.
Greater Fort Lauderdale Alliance president and CEO Bob Swindell added, “We are very happy that ImmunoSite Technologies is expanding in Miramar. The company’s decision to expand in Miramar is a good indicator that our efforts in growing South Florida’s strong life science cluster continue to pay off. We thank the Alliance’s Business Retention and Visitation Outreach (B.R.A.V.O) action team for working with the company through one-on-one meetings.”
For more information on ImmunoSite Technologies, please visit http://immunositetechnologies.com/
CEO and President of ImmunoSite Technologies, LLC, Carlos Aparicio, Ph.D., who has almost 20 years experience in technical and scientific leadership in the pharmaceutical and medical devices industries, said, “ImmunoSite is perfectly positioned to support our clients’ increasing needs for worldwide automation and standardization of biological assays. As a result, we committed to expand our headquarters to a new location in the Miramar Park of Commerce, Miramar, FL, in December 2012, where we could accommodate the increased scientific and administrative staff and the large robotic systems.”
City of Miramar Mayor Lori Moseley stated, “The city is pleased to welcome ImmunoSite Technologies to our community and is excited that their biotechnology expertise further diversifies our corporate base. It is our pleasure to have provided an expedited permitting process for the company which allowed it to become operational within a month’s time.”
“The expansion of ImmunoSite Technologies and other life science firms are the real success stories of Broward County,” said Mason Jackson, president and CEO of WorkForce One Employment Solutions. “WorkForce One looks forward to growing this business sector by continuing to work with ImmunoSite through the recruitment and training process of their employees.”
“Floridian Community Bank partnered with ImmunoSite Technologies on their move to Miramar and expansion efforts by providing working capital financing to the company. We are impressed with the quality of management and excited about future opportunities to continue funding the growth of ImmunoSite,” commented Scott Toth, commercial market manager for Floridian Community Bank.
Greater Fort Lauderdale Alliance president and CEO Bob Swindell added, “We are very happy that ImmunoSite Technologies is expanding in Miramar. The company’s decision to expand in Miramar is a good indicator that our efforts in growing South Florida’s strong life science cluster continue to pay off. We thank the Alliance’s Business Retention and Visitation Outreach (B.R.A.V.O) action team for working with the company through one-on-one meetings.”
For more information on ImmunoSite Technologies, please visit http://immunositetechnologies.com/
No comments:
Post a Comment